SKF-97,541
Chemical compound
| SKF-97,541 | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
SKF-97,541 is a chemical compound that has been studied for its potential pharmacological properties. It is known to interact with various neurotransmitter systems in the brain, which has made it a subject of interest in neuroscience research.
Pharmacology
SKF-97,541 is primarily known for its action as a dopamine receptor agonist. It has been shown to have a high affinity for the D1 dopamine receptor subtype. This interaction suggests that SKF-97,541 could influence dopaminergic pathways in the brain, which are involved in a variety of functions including motor control, reward, and cognition.
Research
Research on SKF-97,541 has explored its potential therapeutic applications. Studies have investigated its effects on Parkinson's disease, a neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the substantia nigra. By stimulating D1 receptors, SKF-97,541 may help to alleviate some of the motor symptoms associated with this condition. Additionally, SKF-97,541 has been studied in the context of schizophrenia and other psychiatric disorders. The compound's ability to modulate dopaminergic activity could make it a candidate for addressing the dopamine hypothesis of schizophrenia, which posits that dysregulated dopamine signaling contributes to the symptoms of the disorder.
Mechanism of Action
The primary mechanism of action of SKF-97,541 involves its agonistic activity at the D1 dopamine receptor. By binding to and activating these receptors, SKF-97,541 can mimic the effects of endogenous dopamine. This activation can lead to increased cyclic AMP (cAMP) production, which is a secondary messenger involved in many intracellular signaling pathways.
Potential Side Effects
As with many compounds that interact with the dopaminergic system, SKF-97,541 may have potential side effects. These could include dyskinesia, which is an abnormality or impairment of voluntary movement, and other motor disturbances. Further research is needed to fully understand the safety profile of this compound.
Conclusion
SKF-97,541 is a compound of interest in the field of neuroscience due to its potent activity at D1 dopamine receptors. Ongoing research aims to elucidate its potential therapeutic applications and safety profile.
See also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
